Clinical Trials Directory

Trials / Sponsors / Servier Bio-Innovation LLC

Servier Bio-Innovation LLC

Industry · 9 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment
IDH1-Mutated Malignancies
Phase 12026-01-14
TerminatedA Study to Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS
Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)/AML, Chronic Myelomonocytic Leukemia (CMML)
Phase 1 / Phase 22025-02-25
Active Not RecruitingA Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroes
MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer
Phase 1 / Phase 22024-08-31
Active Not RecruitingPhase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lu
Non-small Cell Lung Cancer (NSCLC)
Phase 1 / Phase 22024-08-07
RecruitingIvosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previo
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Phase 32024-07-09
RecruitingS095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors Wi
MTAP-deleted Solid Tumors
Phase 1 / Phase 22024-04-29
TerminatedIvosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects With Nonresectable or Metasta
IDH1-mutant Cholangiocarcinoma
Phase 1 / Phase 22023-10-23
CompletedA Phase 1, Open-Label Study to Evaluate the Effect of a Low-Fat Meal and Multiple Doses of Ciprofloxacin on th
Healthy Subjects
Phase 12023-04-14
CompletedA Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody-Anticalin Fusion) in Patients With Solid Tumors
Solid Tumor
Phase 1 / Phase 22021-09-08